1.Randomised...
Claim 5   Evidence 10

2.Menopausal...
Claim 2   Evidence 8

3.A prospective...
Claim 2   Evidence 3

4.Long term...
Claim 4   Evidence 3

5.Quality of...
Claim 3   Evidence 9

6.Placebo-controlled...
Claim 3   Evidence 5

7.Health-related...
Claim 5/4   Evidence 4/5

8.Octreotide...
Claim 5/4   Evidence 6/5

9.2-Weekly...
Claim 4   Evidence 2

10.Early intervention...
Claim 2   Evidence 4

11.Early Intervention...:
Claim 1   Evidence 4

12.Laparoscopic versus...:
Claim 2   Evidence 4

13.Impact of posterior...:
Claim 1   Evidence 4

14.Cisplatin-based therapy...:
Claim 3   Evidence 7

15.A randomized trial...:
Claim 1   Evidence 4

16.Phase III trial...:
Claim 3   Evidence 5

17.Intermittent LHRH...:
Claim 1   Evidence 4

18.SAMITAL\u00ae improves...:
Claim 2   Evidence 6

19.A phase Ib/IIa trial...:
Claim 2   Evidence 4

20.Mediators of physical...:
Claim 2   Evidence 5

21.Randomized clinical...:
Claim 2   Evidence 3

22.Tibetan sound...:
Claim 1   Evidence 1

23.Randomised trial of...:
Claim 1   Evidence 5

24.Prospective randomized...:
Claim 1   Evidence 4

25.Quality of life...:
Claim 2   Evidence 4

26.Efficacy and safety...:
Claim 1   Evidence 8/7

27.Improved quality ...:
Claim 2   Evidence 6

28.A randomised controlled...:
Claim 4   Evidence 3

29.Temozolomide versus...:
Claim 3   Evidence 5

30.Effect of Chinese medicine...:
Claim 2   Evidence 2

31.Five-day oral etoposide...:
Claim 2   Evidence 4

32.Effects of Chinese medicine...:
Claim 1   Evidence 3

33.Cisplatin, dacarbazine....:
Claim 3   Evidence 4

34.Randomized comparison...:
Claim 2   Evidence 5

35.Advanced prostate...:
Claim 5/4   Evidence 8

36.Beneficial effects ...:
Claim 2   Evidence 4

37.Adverse events...:
Claim 2   Evidence 4

38.Preoperative pelvic...:
Claim 2   Evidence 4

39.Short-term...:
Claim 2   Evidence 4

40.Clinical benefit ...:
Claim 3   Evidence 3

41.Once-weekly epoetin...:
Claim 2   Evidence 5

42.A randomized trial...:
Claim 5   Evidence 5

43.Health-related...:
Claim 2   Evidence 7

44.Laparoscopic resection...:
Claim 2   Evidence 7

45.Comparison of...:
Claim 4   Evidence 5

46.Exercise for health:...:
Claim 1   Evidence 4/5

47.Decrease in depression...:
Claim 2   Evidence 3

48.Phase III study...:
Claim 2   Evidence 4

49.Effects of live...:
Claim 1   Evidence 4

50.A randomized, placebo-controlled...:
Claim 1   Evidence 3

51.Long-term outcome...:
Claim 2   Evidence 4

52.Food and Drug...:
Claim 3   Evidence 7

53.Treatment of AIDS-associated...:
Claim 6   Evidence 6

54.Outcomes from the Moving...:
Claim 1   Evidence 3

55.Cisplatin...:
Claim 3   Evidence 5

56.Randomised trial:
Claim 1   Evidence 4

57.Effects of ghrelin...:
Claim 1   Evidence 3

58.Sixteen-week multidrug...:
Claim 3   Evidence 5

59.Stress Management...:
Claim 3   Evidence 5

60.Uterine-artery...:
Claim 2   Evidence 6

61.Effect of dignity therapy...:
Claim 3   Evidence 4

62.Thalidomide...:
Claim 1   Evidence 3

63.Impact of the method ...:
Claim 2   Evidence 4

64.Palliative chemotherapy...:
Claim 2   Evidence 13

65.A multidimensional...:
Claim 2   Evidence 3

66.Topotecan versus...:
Claim 2   Evidence 3

67.Effects of self-directed...:
Claim 2/3   Evidence 4/5

68.Health-related quality...:
Claim 6   Evidence 7

69.The efficacy of...:
Claim 7   Evidence 4

70.Evaluation of glutathione...:
Claim 3   Evidence 2

71.Tirapazamine, cisplatin...:
Claim 1   Evidence 2

72.A randomized controlled...:
Claim 2   Evidence 5

73.Randomized phase III...:
Claim 2   Evidence 5

74.An MRI-based dose--reponse...:
Claim 2   Evidence 3/2

75.Efficacy of low-frequency...:
Claim 3   Evidence 3

76.Impact of psychotherapeutic...:
Claim 1   Evidence 4

77.Identification and...:
Claim 2   Evidence 4

78.Initial evaluation of...:
Claim 1   Evidence 2

79.Long-acting octreotide...:
Claim 1   Evidence 5

80.Quality of life...:
Claim 2   Evidence 4/5

81.Hypofractionated...:
Claim 2   Evidence 10

82.Use of strong opioids...:
Claim 1   Evidence 3

83.Treatment of patients...:
Claim 2   Evidence 8

84.Randomized trial of...:
Claim 1   Evidence 3

85.Symptomatic uterine...:
Claim 3   Evidence 5

86.Treatment of non-metastatic...:
Claim 3   Evidence 4

87.Gender differences...:
Claim 4/2   Evidence 3

88.Long-term effect...:
Claim 3   Evidence 2

89.Lung stereotactic...:
Claim 4   Evidence 4

90.Benefits of supervised...:
Claim 3   Evidence 4

91.Impact of a structured...:
Claim 2   Evidence 2

92.Surgical gastrojejunostomy...:
Claim 2   Evidence 6/5

93.A randomized phase II...:
Claim 3   Evidence 4

94.Six-month follow-up...:
Claim 1/3   Evidence 4

95.Prophylactic swallowing...:
Claim 2   Evidence 4

96.Effect of sertraline...:
Claim 6   Evidence 5/6

97.Randomized multicenter...:
Claim 1   Evidence 4

98.The effectiveness...:
Claim 2   Evidence 3

99.Phase II study of vandetanib...:
Claim 1   Evidence 3

100.The effect of seated...:
Claim 2   Evidence 3